BioSpace News Archive

According to Nova one advisor, the global insilico clinical trials market size was valued at USD 2.6 billion in 2021, and is predicted to be worth around USD 5.0 billion by 2030, registering a CAGR of 7.3% during the forecast period 2022 to 2030.

According to Nova one advisor, the the global Medical Information market gathered revenue around USD 4.1 Billion in 2020 and market is set to grow USD 6.4 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 9.1% during the prediction period 2021 to 2027.

BioScience Managers, the international healthcare investment firm, is pleased to announce the appointment of David Atkins MBA PhD in the role of Managing Partner. Working alongside founder and Managing Partner, Jeremy Curnock Cook, David will be responsible for driving the future growth of BioScience Managers in new and existing geographies and to build on successes in digital health.

ManaMed strives to be at the forefront of medical innovation, which is why it is excited to announce that its DVT prevention device, PlasmaFlow, has just received UnitedHealthcare coverage.

Poxel Announces Upcoming Presentation at the H.C. Wainwright 6th Annual NASH Investor Virtual Conference.

Hospital for Special Surgery, the world’s leading academic medical center focused on musculoskeletal health, and Lumoptik, Inc., a development stage medical device company with a first-in-kind proprietary light-based technology, announced a new collaborative relationship.

Soterix Medical Inc. (SMI), a global leader in non-invasive neuromodulation and synergistic brain monitoring technologies, announced today that it has been awarded a Fast Track grant from the National Institute of Mental Health (NIMH).

City of Hope, one of the largest cancer research and treatment organizations in the U.S., is proud to announce the inaugural Halloween for Hope, an event presented by the organization’s new Junior Board, featuring a soiree full of tricks and treats designed to enchant the entire family.

PADM Medical PRECISION ECO™ Plant based procedural mask with earloops receives emergency use authorization (EUA) from the U.S. FDA – It is the world’s first plant based procedural mask to receive EUA for use in medical and healthcare settings.

ERYTECH Pharma from The Nasdaq Stock Market LLC dated October 7, 2022, indicating that, based upon a closing bid price of less than $1.00 per share for the Company’s American Depositary Shares for the prior 30 consecutive business day period, the Company no longer satisfies Nasdaq Listing Rule 5450.